Skip to main content

Table 1 Baseline demographic and clinical characteristics of patients evaluated for pulmonary rehabilitation (n = 71)

From: Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study

Variables
Age (mean ± SD, years) 60.6 ± 8.8
Gender (%)  
 Male 76.1 (n = 54)
 Female 23.9 (n = 17)
BMI (mean ± SD, kg/m2) 25.8 ± 8.8
Smokers (%)  
 Current smokers 14.1 (n = 10)
 Former smokers 56.3 (n = 40)
 Non smokers 29.6 (n = 21)
Type of thoracic cancer (%)  
 Adenocarcinoma 42.3 (n = 30)
 Squamous cell carcinoma 16.9 (n = 12)
 Small cell carcinoma 5.6 (n = 4)
 Mesothelioma (MPM) 23.9 (n = 17)
 Others 11.3 (n = 8)
Lung cancer TNM stage (%) excluding MPM  
 stage IB 1.9 (n = 1)
 stage IIA 5.6 (n = 3)
 stage IIB 3.7 (n = 2)
 stage IIIA 16.7 (n = 9)
 stage IIIB 11.1 (n = 6)
 stage IV 61.1 (n = 33)
VSRQ total score (mean ± SD) 46.3 ± 17
HAD scale  
 Anxiety score (median + IQR) 7 [5–10]
 Depression score (median + IQR) 6 [3–10]
  1. For quantitative data, results are expressed as mean ± standard deviation (SD) or median with interquartile range (IQR) according to distribution of data. SD standard deviation, BMI body mass index, MPM malignant pleural mesothelioma VSRQ visual simplified respiratory questionnaire global score ranging from 80 (best health status) to 0 (poorest health status) [15], HAD Hospital Anxiety and Depression scale ranging from 0 (best psychological status) to 42 (worse psychological status) [17], IQR interquartile range